Trial intelligence / Profile preview

Lidocaine Infusion for ONSD in Laparoscopic Hysterectomy

NCT05690087Completed

Sponsor
Tanta University
Start
Feb 2023
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in intracranial hypertension (IH), sponsored by Tanta University. Primary endpoint: Optic Nerve Sheath Diameter. Started Feb 2023; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

intracranial hypertension (IH)

Beyond the preview

Go deeper on NCT05690087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05690087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call